2022-11-15T19:51:05-06:00 2021-12-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2021-01-01 521224577 BIOTECHNOLOGY INNOVATION ORGANIZATION BIOT 2029629200 1201 MARYLAND AVE SW NO 900 WASHINGTON DC 20024 STEPHEN JASKO CFO 2029629200 2022-11-15 1 STEPHEN JASKO XXX-XX-XXXX LAURA J KENNEY P00202198 6177170831 2022-11-15 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z MICHELLE MCMURRY-HEATH 1201 MARYLAND AVE SW NO 900 WASHINGTON DC 20024 99740284 0 X WWW.BIO.ORG X 1993 DC SUPPORT THE BIOTECHNOLOGY INDUSTRY AND TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND. 96 95 203 97 1153688 544386 0 154941 41958016 52920414 6102556 6180523 29218945 21654962 77279517 80910840 2976500 2103465 0 0 40492059 34982444 0 0 0 38376099 42972209 81844658 80058118 -4565141 852722 76544473 113666319 32801999 69410674 43742474 44255645 X THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2021 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT BIOETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.-ADVOCATED FOR THE MODERNIZATION OF THE CLINICAL DEVELOPMENT PARADIGMTHE EMERGING COMPANIES SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR FISCAL POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE FOOD & AGRICULTURE SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS FOR AG-BIOTECH PRODUCTS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - ADVOCATED IN LEGISLATURES AND COURTS TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2021 ADVOCACY ACCOMPLISHMENTS: - SUPPORTED A RENEWABLE CHEMICALS REPORT.- ADVOCATED FOR EPA TO TREAT ALL SUSTAINABLY SOURCED BIOMASS AS ELIGIBLE MEASURES FOR EMISSIONS REDUCTION CREDIT (ERC) GENERATION. - ADVOCATED REGARDING THE IMPLEMENTATION OF THE TOXIC SUBSTANCES CONTROL ACT (TSCA) AS AMENDED BY CONGRESS, AS WELL AS ISSUES RELATING TO THE NATIONAL BIOENGINEERED FOOD DISCLOSURE ACT.- ENGAGED WITH THE ADMINISTRATION'S REVIEW OF THE COORDINATED FRAMEWORK FOR BIOTECHNOLOGY, INCLUDING WITH RESPECT TO THE REGULATION OF GENETICALLY ENGINEERED (GE) ALGAE. SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 76 COUNTRIES AND 48 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. 0 1 0 1 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 129 0 1 203 1 1 1 1 IN 0 0 1 0 0 1 0 X 96 95 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X STEPHEN JASKO 2029629200 1201 NEW YORK AVE NW SUITE 1300 WASHINGTON DC 20005 JULIE GERBERDING SECRETARY 2.00 X X 0 0 0 JEREMY LEVIN IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 ELIZABETH LEWIS SECRETARY 2.00 X X 0 0 0 JOHN MARAGANORE IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 HELEN TORLEY UNTIL 121 SECRETARY 2.00 X X 0 0 0 BRADFORD ZAKES TREASURER 2.00 X X 0 0 0 STEVE ALBERS DIRECTOR 2.00 X 0 0 0 ANNE ALONZO UNTIL 921 DIRECTOR 2.00 X 0 0 0 BONNIE ANDERSON DIRECTOR 2.00 X 0 0 0 STUART ARBUCKLE DIRECTOR 2.00 X 0 0 0 MARTIN BABLER DIRECTOR 2.00 X 0 0 0 DUANE BARNES UNTIL 121 DIRECTOR 2.00 X 0 0 0 LAURA BEREZIN UNTIL 121 DIRECTOR 2.00 X 0 0 0 DOUG BERVEN DIRECTOR 2.00 X 0 0 0 JEAN-JACQUES BIENAIME DIRECTOR 2.00 X 0 0 0 FRITZ BITTENBENDER DIRECTOR 2.00 X 0 0 0 CHRISTOPHER BOERNER DIRECTOR 2.00 X 0 0 0 CHRISTOPHE BOURDON UNTIL 321 DIRECTOR 2.00 X 0 0 0 CARRIE BOURDOW DIRECTOR 2.00 X 0 0 0 CARINE BOUSTANY DIRECTOR 2.00 X 0 0 0 BRIAN BRAZEAU UNTIL 821 DIRECTOR 2.00 X 0 0 0 STEPHANIE BROWN UNTIL 1121 DIRECTOR 2.00 X 0 0 0 VICTOR BULTO DIRECTOR 2.00 X 0 0 0 EMMANUEL CAEYMAEX DIRECTOR 2.00 X 0 0 0 KAY CHANDLER DIRECTOR 2.00 X 0 0 0 IVAN CHEUNG DIRECTOR 2.00 X 0 0 0 MEENU CHHABRA KASON UNTIL 321 DIRECTOR 2.00 X 0 0 0 GIACOMO CHIESI DIRECTOR 2.00 X 0 0 0 JEFFREY CLELAND DIRECTOR 2.00 X 0 0 0 RON COHEN DIRECTOR 2.00 X 0 0 0 GRACE COLON DIRECTOR 2.00 X 0 0 0 BRUCE COZADD DIRECTOR 2.00 X 0 0 0 JOHN CROWLEY DIRECTOR 2.00 X 0 0 0 ROGER CRYSTAL DIRECTOR 2.00 X 0 0 0 DOUGLAS DOERFLER DIRECTOR 2.00 X 0 0 0 MARK DROZDOWSKI UNTIL 621 DIRECTOR 2.00 X 0 0 0 ERIC DUBE DIRECTOR 2.00 X 0 0 0 MARK ENYEDY DIRECTOR 2.00 X 0 0 0 BARRY FLANNELLY DIRECTOR 2.00 X 0 0 0 ALEXANDRIA FORBES DIRECTOR 2.00 X 0 0 0 CEDRIC FRANCOIS DIRECTOR 2.00 X 0 0 0 BRIAN GOFF UNTIL 721 DIRECTOR 2.00 X 0 0 0 KEVIN GORMAN DIRECTOR 2.00 X 0 0 0 JUSTIN GOVER UNTIL 521 DIRECTOR 2.00 X 0 0 0 PATRICK GRUBER DIRECTOR 2.00 X 0 0 0 CHIRFI GUINDO DIRECTOR 2.00 X 0 0 0 SEBASTIAN GUTH DIRECTOR 2.00 X 0 0 0 STEVEN HARR DIRECTOR 2.00 X 0 0 0 PAUL HASTINGS DIRECTOR 2.00 X 0 0 0 RACHEL HAURWITZ DIRECTOR 2.00 X 0 0 0 CHRISTOPHER HEALEY DIRECTOR 2.00 X 0 0 0 JENNIFER HOLMGREN DIRECTOR 2.00 X 0 0 0 SCOTT HOLMSTROM UNTIL 921 DIRECTOR 2.00 X 0 0 0 PATRIK JONSSON DIRECTOR 2.00 X 0 0 0 ALEX KARNAL DIRECTOR 2.00 X 0 0 0 DANIEL KEIL DIRECTOR 2.00 X 0 0 0 DAVID KETTNER DIRECTOR 2.00 X 0 0 0 JEFFREY KINDLER UNTIL 621 DIRECTOR 2.00 X 0 0 0 RACHEL KING DIRECTOR 2.00 X 0 0 0 SCOTT KOENIG DIRECTOR 2.00 X 0 0 0 SAMARTH KULKARNI DIRECTOR 2.00 X 0 0 0 JOSEPH LAROSA DIRECTOR 2.00 X 0 0 0 JOHN LEPORE DIRECTOR 2.00 X 0 0 0 NICK LESCHLY UNTIL 1221 DIRECTOR 2.00 X 0 0 0 TED LOVE DIRECTOR 2.00 X 0 0 0 SANDY MACRAE DIRECTOR 2.00 X 0 0 0 GAIL MADERIS DIRECTOR 2.00 X 0 0 0 PAIGE MAHANEY UNTIL 521 DIRECTOR 2.00 X 0 0 0 AAMIR MALIK DIRECTOR 2.00 X 0 0 0 AMEET MALLIK UNTIL 421 DIRECTOR 2.00 X 0 0 0 SHARON MATES DIRECTOR 2.00 X 0 0 0 THOMAS MATHERS DIRECTOR 2.00 X 0 0 0 JOHN MELO DIRECTOR 2.00 X 0 0 0 BOB MORE DIRECTOR 2.00 X 0 0 0 MICHAEL MORRISSEY DIRECTOR 2.00 X 0 0 0 MICHAEL NARACHI DIRECTOR 2.00 X 0 0 0 AMIR NASHAT DIRECTOR 2.00 X 0 0 0 WILLIAM NEWELL DIRECTOR 2.00 X 0 0 0 JULIA OWENS DIRECTOR 2.00 X 0 0 0 JOHN OYLER DIRECTOR 2.00 X 0 0 0 RICHARD PAULSON UNTIL 521 DIRECTOR 2.00 X 0 0 0 ADELENE PERKINS DIRECTOR 2.00 X 0 0 0 MARK PLATT DIRECTOR 2.00 X 0 0 0 RICHARD POPS DIRECTOR 2.00 X 0 0 0 MARK PRUZANSKI DIRECTOR 2.00 X 0 0 0 SOFIE QIAO DIRECTOR 2.00 X 0 0 0 MICHAEL RAAB DIRECTOR 2.00 X 0 0 0 ANNA RATH DIRECTOR 2.00 X 0 0 0 ELENA RICE DIRECTOR 2.00 X 0 0 0 HOWARD ROBIN DIRECTOR 2.00 X 0 0 0 MICHAEL RUGGIERO DIRECTOR 2.00 X 0 0 0 AMBER SALZMAN UNTIL 621 DIRECTOR 2.00 X 0 0 0 JAMES SAPIRSTEIN DIRECTOR 2.00 X 0 0 0 GEORGE SCANGOS UNTIL 621 DIRECTOR 2.00 X 0 0 0 CHRISTOPHE SCHILLING DIRECTOR 2.00 X 0 0 0 DIANE SHANAHAN UNTIL 921 DIRECTOR 2.00 X 0 0 0 CHRISTI SHAW DIRECTOR 2.00 X 0 0 0 JEFFREY SHERMAN DIRECTOR 2.00 X 0 0 0 BILL SIBOLD DIRECTOR 2.00 X 0 0 0 NANCY SIMONIAN DIRECTOR 2.00 X 0 0 0 DUANE SIMPSON DIRECTOR 2.00 X 0 0 0 ERIKA SMITH DIRECTOR 2.00 X 0 0 0 JULIE ANNE SMITH UNTIL 821 DIRECTOR 2.00 X 0 0 0 ELAINE SORG DIRECTOR 2.00 X 0 0 0 CHRISTOPHER STANDLEE UNTIL 121 DIRECTOR 2.00 X 0 0 0 EDDIE SULLIVAN DIRECTOR 2.00 X 0 0 0 JENNIFER TAUBERT UNTIL 121 DIRECTOR 2.00 X 0 0 0 IAN THOMPSON DIRECTOR 2.00 X 0 0 0 LINDA TROLINDER DIRECTOR 2.00 X 0 0 0 MARK TRUDEAU DIRECTOR 2.00 X 0 0 0 RICK TURNER UNTIL 1121 DIRECTOR 2.00 X 0 0 0 GIL VAN BOKKELEN UNTIL 521 DIRECTOR 2.00 X 0 0 0 TIMOTHY WALBERT UNTIL 521 DIRECTOR 2.00 X 0 0 0 OLIVER WALKER DIRECTOR 2.00 X 0 0 0 HENRIK WAREBORN DIRECTOR 2.00 X 0 0 0 NEIL WARMA DIRECTOR 2.00 X 0 0 0 SUE WASHER DIRECTOR 2.00 X 0 0 0 FRANK WATANABE DIRECTOR 2.00 X 0 0 0 ANNE WHITE UNTIL 1021 DIRECTOR 2.00 X 0 0 0 SCOTT WHITE DIRECTOR 2.00 X 0 0 0 ROBERT WILLS UNTIL 621 DIRECTOR 2.00 X 0 0 0 RICK WINNINGHAM DIRECTOR 2.00 X 0 0 0 SYLVIA WULF DIRECTOR 2.00 X 0 0 0 ROGER WYSE DIRECTOR 2.00 X 0 0 0 JOHN YOUNG UNTIL 1221 DIRECTOR 2.00 X 0 0 0 BERNHARDT ZEIHER UNTIL 321 DIRECTOR 2.00 X 0 0 0 JILL ZULLO DIRECTOR 2.00 X 0 0 0 MICHELLE MCMURRY-HEATH PRESIDENT AND CEO 40.00 X 2050133 0 264622 STEPHEN JASKO CHIEF FINANCIAL OFFICER 40.00 X 506022 0 33551 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY 40.00 X 1355976 0 39096 RICH MASTERS CHIEF PUBLIC AFFAIRS OFFICER 40.00 X 643726 0 45694 ELIZABETH ESHAM CHIEF SCIENCE OFFICER 40.00 X 605569 0 43889 PETER MCHUGH CHIEF LEGAL OFFICER 40.00 X 558879 0 56671 JOSEPH DAMOND DEPUTY CHIEF POLICY OFFICER & EVP INTERNATIONAL AF 40.00 X 533658 0 77891 SHAYE MANDLE COO 40.00 X 522185 0 33551 6776148 0 594965 97 0 1 0 THE HERALD GROUP LLC 1800 M STREET NW SUITE 450 SOUTH WASHINGTON DC 20036 CONVENTION CENTER RENTAL 2100000 SIDLEY AUSTIN LLP PO BOX 0642 CHICAGO IL 60690 CONSULTING 1247540 PUBLIC GOOD PROJECTS 2308 MOUNT VERNON AVENUE SUITE 758 ALEXANDRIA VA 22301 CONSULTING 883000 KEYBRIDGE COMMUNICATIONS 1722-A WISCONSIN AVENUE NW SUITE 2 WASHINGTON DC 20007 CONSULTING 879787 360 LIVE MEDIA LLC 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 CONSULTING 832500 61 154941 154941 MEMBERSHIP DUES 900003 32415003 32415003 CONFERENCE/MEETING REVENUE 541800 11316867 10939822 377045 SPECIAL INITIATIVES 900003 7457234 7457234 CBI LOBBYING FUND 900003 1062280 1062280 LEGAL & POLICY SUPPORT 900003 533218 533218 135812 135812 52920414 1939051 1939051 19182040 766643 18415397 23070916 18829444 4241472 4241472 4241472 INSURANCE CLAIMS REVENUE 524298 2373400 2373400 TAX REFUND 900003 89522 89522 BIONEWS ADS INCOME 900003 10000 10000 2472922 80910840 52543369 1153688 27058842 X 2097401 6064 7466183 28315 22960292 90132 3113155 1324367 458376 78271 5204776 48027 13011664 1392500 490851 1178794 6940556 492326 3846620 1380 8147829 518945 170219 DUES & SUBSCRIPTIONS 339980 TAXES PAID 338787 OUTREACH 264890 BIO LEGISLATIVE DAY/FLY 38940 8478 80058118 15487112 8880294 967224 4248582 4288721 5336669 2624031 3636584 19151472 8092576 776734 11058896 52400651 52911446 0 27593848 76544473 113666319 18997300 18109640 12264522 10845666 1540177 40455368 32801999 69410674 X 43742474 44255645 43742474 44255645 76544473 113666319 852722 -339551 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 1 32415003 10444118 305942 10750060 13290151 -2540091 17146255 6235809 10910446 276745 276746 -1 1728472 1580021 148451 11058896 RIGHT OF USE ASSET - OPERATING 27593848 27593848 LEASE LIABILITY - OPERATING 40194879 BIO-PAC 260489 40455368 80523262 -339551 -339551 80862813 48027 48027 80910840 80010091 0 80010091 48027 48027 80058118 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM GRANT-MAKING CONFERENCES, ADVOCACY AND EDUCATION 6064 SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, PROGRAM SERVICES ADVOCACY 18389 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SERVICES ADVOCACY 145071 0 0 0 0 0 0 169524 0 169524 EUROPE (INCLUDING ICELAND & GREENLAND) CONTRIBUTION 6064 WIRE TRANSFER 0 1 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION HAS SUPPORTING DOCUMENTATION FOR THE AMOUNT THAT IS INVOICED FROM THE COMPANIES. PART III ACCOUNTING METHOD: 1 ALLIANCE FOR AGING RESEARCH 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 541379174 501(C)(3) 15000 0 SPONSORSHIP ALLIANCE TO PROTECT MEDICAL INNOVATION 1220 L ST NW SUITE 100 488 WASHINGTON DC 20005 831354631 501(C)(4) 50000 0 CONTRIBUTION AMERICAN BONE HEALTH 4208 SIX FORKS RD SUITE 1000 RALEIGH NC 27609 931022954 501(C)(3) 10000 0 SUPPORT AMERICAN BRAIN COALITION PO BOX 1549 MAPLE GROVE MN 55311 201852597 501(C)(3) 10000 0 SUPPORT AMERICAN CANCER SOCIETY ACTION NETWORK INC 555 11TH STREET SUITE 300 WASHINGTON DC 20004 522340031 501(C)(4) 25000 0 SPONSORSHIP AMERICAN LUNG ASSOCIATION 55 W WACKER DRIVE SUITE 1150 CHICAGO IL 60601 131632524 501(C)(3) 15000 0 SUPPORT ARTHRITIS FOUNDATION INC 1355 PEACHTREE ST 600 ATLANTA GA 30309 581341679 501(C)(3) 15000 0 SUPPORT ASIAN AND PACIFIC ISLANDER AMERICAN HEALTH FORUM ONE KAISER PLAZA SUITE 850 OAKLAND CA 94612 943030866 501(C)(3) 20000 0 GIFT/SUPPORT ASSOCIATION OF ASIAN PACIFIC COMMUNITY HEALTH ORGANIZATIONS 2140 SHATTUCK AVE SUITE 203 BERKELEY CA 94704 943050247 501(C)(3) 60000 0 GIFT BIONJ INC 1255 WHITEHORSE-MERCERVILLE RD BUILDING B - SUITE 514 TRENTON NJ 08619 223284393 501(C)(6) 45000 0 SPONSORSHIP BIOUTAH PO BOX 58531 SALT LAKE CITY UT 84158 900899204 501(C)(6) 6500 0 SUPPORT CALIFORNIA LIFE SCIENCES ASSOCIATION 9191 TOWNE CENTRE DRIVE SUITE 450 SAN DIEGO CA 92122 473226523 501(C)(6) 200000 0 SUPPORT CANCER SUPPORT COMMUNITY 734 15TH STREET NW SUITE 300 WASHINGTON DC 20005 954163931 501(C)(3) 30000 0 SUPPORT CAPITAL CLUBHOUSE INC 1517 18TH ST NW WASHINGTON DC 20036 454366185 501(C)(3) 15000 0 SUPPORT CENTER FOR FOOD INTEGRITY 2900 NE BROOKTREE LANE SUITE 200 GLADSTONE MO 64119 204662713 501(C)(4) 50000 0 SPONSORSHIP CENTER FORWARD 1214A INGLESIDE AVE MCLEAN VA 22101 272429741 501(C)(4) 35000 0 2021 ANNUAL STAKEHOLDER PROGRAM COLORADO BIOSCIENCE ASSOCIATION 600 GRANT STREET SUITE 306 DENVER CO 80203 841363258 501(C)(6) 15000 0 SPONSORSHIP COMMUNITY LIVER ALLIANCE 100 W STATION SQUARE DR SUITE 1945 PITTSBURGH PA 15219 461909171 501(C)(3) 15000 0 SUPPORT COPD FOUNDATION INC 3300 PONCE DE LEON BLVD MIAMI FL 33134 201048322 501(C)(3) 15000 0 SUPPORT CYSTIC FIBROSIS RESEARCH FUND INC 100 ST GEORGES RD UNIT G1 ARDMORE PA 19003 453768161 501(C)(3) 10000 0 SUPPORT DELAWARE BIOSCIENCE ASSOCIATION 1 INNOVATION WAY SUITE 300 NEWARK DE 19711 204147195 501(C)(6) 8000 0 SUPPORT DEPRESSION AND BIPOLAR SUPPORT ALLIANCE 55 E JACKSON BLVD SUITE 490 CHICAGO IL 60604 363379124 501(C)(3) 10000 0 SUPPORT DUP15Q ALLIANCE 1207 LINDEN AVE PARK RIDGE IL 60068 200751232 501(C)(3) 10000 0 SUPPORT EPILEPSY FOUNDATION 8301 PROFESSIONAL PLACE EAST SUITE 200 LANDOVER MD 20785 520856660 501(C)(3) 15000 0 SUPPORT EVERYLIFE FOUNDATION FOR RARE DISEASES 1012 14TH ST NW SUITE 500 WASHINGTON DC 20005 264614274 501(C)(3) 50000 0 SUPPORT/CONTRIBUTION FARMERS ALLIANCE FOR INTEGRATED RESOURCES 1260 COUNTY ROAD 20 1/2 LONGMONT CO 80504 454591729 501(C)(5) 20000 0 SUPPORT FATTY LIVER FOUNDATION 3938 E SHADY GLEN CT BOISE ID 83706 814492542 501(C)(3) 10000 0 SUPPORT FOUNDATION FOR SARCOIDOSIS RESEARCH 1820 WEST WEBSTER AVENUE SUITE 304 CHICAGO IL 60614 364378232 501(C)(3) 16500 0 SUPPORT GENETIC ALLIANCE 4301 CONNECTICUT AVENUE NW SUITE 404 WASHINGTON DC 20008 521571905 501(C)(3) 15000 0 SUPPORT GEORGE MASON UNIVERSITY FOUNDATION INC 3301 FAIRFAX DRIVE MSN 1G3 ARLINGTON VA 22201 541603842 501(C)(3) 10000 0 DONATION GEORGIA BIO 999 PEACHTREE AVE NE ATLANTA GA 30309 581849665 501(C)(3) 15000 0 SPONSORSHIP GLOBAL DOWN SYNDROME FOUNDATION 3239 E 2ND AVE DENVER CO 80206 264431001 501(C)(3) 6000 0 SUPPORT GO2 FOUNDATION FOR LUNG CANCER 1100 INDUSTRIAL ROAD SUITE 1 SAN CARLOS CA 94070 204417327 501(C)(3) 10000 0 SUPPORT HAWAII CROP IMPROVEMENT ASSOCIATION PO BOX 126 AIEA HI 96701 990258882 501(C)(6) 25000 0 SUPPORT HEALTHYWOMEN 1 HARDING RD SUITE 102A RED BANK NJ 77010 521624846 501(C)(3) 8500 0 SUPPORT HEPATITIS B FOUNDATION 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 232655669 501(C)(3) 15000 0 SUPPORT HIV AND HEPATITIS POLICY INSTITUTE 1602B BELMONT ST NW WASHINGTON DC 20009 844147678 501(C)(3) 7500 0 SUPPORT HUNTER'S HOPE FOUNDATION INC PO BOX 643 6368 W QUAKER ORCHARD PARK NY 14127 161552315 501(C)(3) 15000 0 SUPPORT INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION 700 K ST NW SUITE 600 WASHINGTON DC 20001 204403497 501(C)(3) 30000 0 SUPPORT LIFE SCIENCE WASHINGTON 1551 EASTLAKE AVE E SUITE 300 SEATTLE WA 98102 911453398 501(C)(6) 10000 0 SUPPORT LITTLE HERCULES FOUNDATION 5522 AVERY RD DUBLIN OH 43016 461427334 501(C)(3) 15000 0 SUPPORT LULAC INSTITUTE INC 1133 19TH ST NW SUITE 1000 WASHINGTON DC 20036 522072106 501(C)(3) 150000 0 GIFT LUPUS FOUNDATION OF AMERICA INC 2121 K STREET NW SUITE 200 WASHINGTON DC 20037 431131436 501(C)(3) 7500 0 SPONSORSHIP LUPUS RESEARCH ALLIANCE INC 275 MADISON AVE 10TH FLOOR NEW YORK NY 10016 582492929 501(C)(3) 15000 0 SUPPORT MASSACHUSETTS BIOTECH COUNCIL 300 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 222693047 501(C)(6) 6000 0 SPONSORSHIP MONTANA BIOSCIENCE ALLIANCE P O BOX 1773 BILLINGS MT 59106 201647600 501(C)(3) 20000 0 SUPPORT NATIONAL ALLIANCE ON MENTAL ILLNESS 3803 N FAIFAX DR SUITE 100 ARLINGTON VA 22203 431201653 501(C)(3) 15000 0 SUPPORT NATIONAL BLACK CHURCH INITIATIVE POBOX 65177 WASHINGTON DC 20035 522169774 501(C)(3) 91400 0 SUPPORT/GIFT NATIONAL BLOOD CLOT ALLIANCE PO BOX 825687 PHILADELPHIA PA 19182 562425135 501(C)(3) 10000 0 SUPPORT NATIONAL CAUCUS AND CENTER ON BACK AGING 1220 L ST NW SUITE 800 WASHINGTON DC 20005 237455377 501(C)(3) 30000 0 SUPPORT NATIONAL CONFERENCE OF STATE LEGISLATURES 7700 EAST FIRST PLACE DENVER CO 80230 840772595 170(C)(1) 10000 0 SPONSORSHIP NATIONAL COUNCIL OF ASIAN PACIFIC ISLANDER PHYSICIANS 2144 BEACH STREET SAN FRANCISCO CA 94123 273429376 501(C)(3) 50000 0 SUPPORT NATIONAL COUNCIL ON AGING 251 18TH ST SOUTH SUITE 500 ARLINGTON VA 22202 131932384 501(C)(3) 45000 0 SPONSORSHIP NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 20036 131624107 501(C)(3) 49000 0 SPONSORSHIP NATIONAL HISPANIC MEDICAL ASSOCIATION 1920 L STREET NW SUITE 725 WASHINGTON DC 20036 521884446 501(C)(6) 30000 0 AWARD NATIONAL PSORIASIS FOUNDATION 6600 SW 92ND AVE SUITE 300 PORTLAND OR 97223 930571472 501(C)(3) 15000 0 SUPPORT NATIONAL URBAN LEAGUE INC 80 PINE STREET 9TH FLOOR NEW YORK NY 10005 131840489 501(C)(3) 150000 0 GIFT NCSL FOUNDATION FOR STATE LEGISLATURES 7700 EAST FIRST PLACE DENVER CO 80230 742232576 501(C)(3) 7500 0 SPONSORSHIP NUS AMERICA FOUNDATION INC 440 NORTH WOLFE ROAD SUNNYVALE CA 94085 202368621 501(C)(3) 16000 0 DONATION OREGONIANS FOR FOOD AND SHELTER 1149 COURT ST NE SUITE 110 SALEM OR 97301 930775640 501(C)(6) 17500 0 SUPPORT PREVENT BLINDNESS 225 WEST WACKER DRIVE SUITE 400 CHICAGO IL 60606 363667121 501(C)(3) 15500 0 SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE ST SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 8000 0 SPONSORSHIP RESEARCHAMERICA 241 18TH STREET SOUTH SUITE 501 ARLINGTON VA 22202 521609875 501(C)(3) 6000 0 SUPPORT SERVICES AND ADVOCACY FOR GAY LESBIAN BISEXUAL AND TRANSGENDER ELDERS IN 305 7THAVE 15TH FLOOR NEW YORK NY 10001 132947657 501(C)(3) 20000 0 SUPPORT SICK CELLS 4512 RIVER DRIVE LISLE IL 60532 813481633 501(C)(3) 65000 0 SUPPORT ST BALDRICK'S FOUNDATION 1333 S MAYFLOWER AVE SUITE 400 MONROVIA CA 91016 201173824 501(C)(3) 15000 0 SUPPORT SYNGAP1 FOUNDATION 15319 REDBUD BERRY WAY CYPRESS TX 77433 472459997 501(C)(3) 15000 0 SUPPORT THE BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS ST MAIL CODE 300 FENWAY R BOSTON MA 02115 042312909 501(C)(3) 10000 0 SPONSORSHIP THE CONGRESSIONAL INSTITUTE INC 1700 DIAGONAL RD SUITE 300 ALEXANDRIA VA 22314 521504189 501(C)(4) 15000 0 SUPPORT THE GERONTOLOGICAL SOCIETY OF AMERICA 1220 L STREET NW 901 WASHINGTON DC 20005 521256181 501(C)(3) 10000 0 SUPPORT THE GLOBAL FOUNDATION FOR PEROXISOMAL DISORDERS PO BOX 33238 TULSA OK 74135 273646193 501(C)(3) 15000 0 SUPPORT THE GLOBAL WOMEN'S INNOVATION NETWORK 233 PENNSYLVANIA AVENUE SE 2ND FLOOR WASHINGTON DC 20003 271428117 501(C)(3) 50000 0 SUPPORT THE GOVERNING MAJORITY EDUCATION FUND 606 W WISCONSIN AVE 1202 MILWAUKEE WI 53203 850549304 501(C)(4) 25000 0 CONTRIBUTION THE NATIONAL HEMOPHILIA FOUNDATION 7 PENN PLAZA SUITE 1204 NEW YORK NY 10001 135641857 501(C)(3) 15000 0 SUPPORT THE ULMAN CANCER FUND OF YOUNG ADULTS INC 2118 E MADISON ST BALTIMORE MD 21205 522057636 501(C)(3) 15000 0 SUPPORT US CHAMBER OF COMMERCE 1615 H STREET NW P O BOX 1200 WASHINGTON DC 20062 530045720 501(C)(6) 25000 0 SUPPORT UNITED SPINAL ASSOCIATION 120-34 QUEENS BLVD SUITE 320 KEW GARDENS NY 11415 135612621 501(C)(3) 10000 0 SUPPORT US CHAMBER OF COMMERCE 1615 H STREET NW PO BOX 1200 WASHINGTON DC 20062 530045720 501(C)(6) 25000 0 SUPPORT WOMEN OF COLOR IN PHARMA PO BOX 6172 SOMERSET NJ 08875 813871261 501(C)(6) 10000 0 SPONSORSHIP ZERO - THE PROJECT TO END PROSTATE CANCER 515 KING STREET SUITE 420 ALEXANDRIA VA 22314 593400922 501(C)(3) 15000 0 SUPPORT 59 80 PART I, LINE 2: BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. X 0 1 X X X X X 1 1 0 MICHELLE MCMURRY-HEATH PRESIDENT AND CEO 1197646 0 851887 0 600 0 233700 0 30922 0 2314755 0 0 0 THOMAS DILENGE PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC 210960 0 522501 0 622515 0 8700 0 30396 0 1395072 0 0 0 RICH MASTERS CHIEF PUBLIC AFFAIRS OFFICER 488126 0 155000 0 600 0 8700 0 36994 0 689420 0 0 0 ELIZABETH ESHAM CHIEF SCIENCE OFFICER 479958 0 125011 0 600 0 8700 0 35189 0 649458 0 0 0 PETER MCHUGH CHIEF LEGAL OFFICER 448606 0 109673 0 600 0 8700 0 47971 0 615550 0 0 0 JOSEPH DAMOND DEPUTY CHIEF POLICY OFFICER & EVP IN 409070 0 123988 0 600 0 26200 0 51691 0 611549 0 0 0 SHAYE MANDLE COO 471585 0 50000 0 600 0 0 0 33551 0 555736 0 0 0 STEPHEN JASKO CHIEF FINANCIAL OFFICER 450422 0 55000 0 600 0 0 0 33551 0 539573 0 0 0 PART I, LINES 4A-B THE ORGANIZATION HAS A NONQUALIFIED DEFERRED COMPENSATION PLAN. UNDER THE TERMS OF THE PLAN, THE PARTICIPANTS ARE ENTITLED TO BENEFITS IF THEY REMAIN EMPLOYED BY THE ORGANIZATION UNTIL A PREDETERMINED TIME. THE PLAN IS INTENDED TO BE A NONQUALIFIED, UNFUNDED PROGRAM FOR THE BENEFIT OF A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES OF BIO WITHIN THE MEANING OF ERISA. THE FOLLOWING WERE CONTRIBUTIONS MADE DURING 2021: MICHELLE MCMURRY-HEATH: $225,000 THOMAS DILENGE RECEIVED A ONE-TIME SEVERANCE PAYMENT OF $622,515 UPON SEPARATION OF SERVICE DURING THE TAX YEAR. LILY DOEFLER DAUGHTER OF A BOARD MEMBER 28315 EMPLOYMENT 0 FORM 990, PART VI, SECTION A, LINE 1A THE BOARD OF DIRECTORS SHALL DESIGNATE BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN TWENTY-THREE (23) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS WITH INFORMATION PROVIDED BY AND UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY KEY EMPLOYEES, OFFICERS AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15 FOR 2021, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO (BIOTECHNOLOGY INNOVATION ORGANIZATION 52-1224577) WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2021, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART IX, LINE 11G BIO-PAC ADMINISTRATIVE 29,094. BUSINESS STRATEGIES 4,034. CONSULTANTS AND OTHER PROFESSIONAL FEES 3,664,915. EC EMERGING PRIORITIES -38,110. ECONOMIC STUDIES 254,335. EDUCATION 222,222. I&E INITIATIVES 9,100. PROGRAM INITIATIVES 45,170. RECRUITMENT 233,749. RESEARCH/FOCUS GROUPS -7,500. TEMPORARY HELP 257,852. CBI LOBBYING FUND 1,062,280. SPECIAL INITIATIVES 7,274,523. EXCELLENCE THROUGH STEWARDSHIP 1201 MARYLAND AVE SW SUITE 900 WASHINGTON DC 20024 263021330 TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE PROMISE, ACHIEVEMENTS DC 501(C)(4) 0 BIOTECHNOLOGY INSTITUTE 1201 MARYLAND AVE SW SUITE 900 WASHINGTON DC 20024 251716917 TO SUPPORT THE PURSUIT OF LIFELONG LEARNING ABOUT THE CHALLENGES OF BIOTECH. DC 501(C)(3) LINE 7 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 EXCELLENCE THROUGH STEWARDSHIP B 54996 EXCELLENCE THROUGH STEWARDSHIP Q 38371 THE BIOTECHNOLOGY INSTITUTE D 84004 THE BIOTECHNOLOGY INSTITUTE B 55240